Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05121025 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pathogen-microbiome Interaction During Helicobacter Pylori Infection

Study acronym: PREDICTHP
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 5, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 30, 2024 to Jun 30, 2025
    • Study completion date: Jun 1, 2025 to Dec 30, 2025
    v4
  2. Primary completion date: Jun 30, 2023 to Jun 30, 2024
    • Study completion date: Dec 1, 2024 to Jun 1, 2025
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 1, 2022 to Mar 11, 2022
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Helicobacter pylori affects the gut microbiome in ways that are only partially understood. In which patients H. pylori causes severe disease and in whom it merely colonizes, possibly even with beneficial effects, is not understood. The investigators are pursuing the hypothesis that changes in the gut microbiome that can be easily measured in stool have such predictive value.
Trial Details
NCT Number NCT05121025
Lead Sponsor University Hospital Freiburg
Conditions
(from sponsor)		 Helicobacter Pylori Infection
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov